全文获取类型
收费全文 | 298121篇 |
免费 | 17708篇 |
国内免费 | 417篇 |
专业分类
耳鼻咽喉 | 4251篇 |
儿科学 | 10368篇 |
妇产科学 | 10338篇 |
基础医学 | 45075篇 |
口腔科学 | 7606篇 |
临床医学 | 24289篇 |
内科学 | 56092篇 |
皮肤病学 | 6331篇 |
神经病学 | 21339篇 |
特种医学 | 11725篇 |
外国民族医学 | 43篇 |
外科学 | 47331篇 |
综合类 | 7746篇 |
现状与发展 | 1篇 |
一般理论 | 163篇 |
预防医学 | 19927篇 |
眼科学 | 6980篇 |
药学 | 21076篇 |
中国医学 | 750篇 |
肿瘤学 | 14815篇 |
出版年
2019年 | 2326篇 |
2018年 | 3725篇 |
2017年 | 2722篇 |
2016年 | 3153篇 |
2015年 | 3577篇 |
2014年 | 4712篇 |
2013年 | 7420篇 |
2012年 | 9313篇 |
2011年 | 9735篇 |
2010年 | 6272篇 |
2009年 | 5680篇 |
2008年 | 8888篇 |
2007年 | 9710篇 |
2006年 | 9536篇 |
2005年 | 9134篇 |
2004年 | 8825篇 |
2003年 | 8288篇 |
2002年 | 7918篇 |
2001年 | 13417篇 |
2000年 | 13731篇 |
1999年 | 11427篇 |
1998年 | 2907篇 |
1997年 | 2631篇 |
1996年 | 2499篇 |
1995年 | 2557篇 |
1994年 | 2352篇 |
1992年 | 8374篇 |
1991年 | 8508篇 |
1990年 | 8303篇 |
1989年 | 8119篇 |
1988年 | 7344篇 |
1987年 | 7116篇 |
1986年 | 6753篇 |
1985年 | 6542篇 |
1984年 | 4777篇 |
1983年 | 4138篇 |
1982年 | 2468篇 |
1979年 | 4435篇 |
1978年 | 3223篇 |
1977年 | 2728篇 |
1976年 | 2496篇 |
1975年 | 2830篇 |
1974年 | 3358篇 |
1973年 | 3380篇 |
1972年 | 3123篇 |
1971年 | 2955篇 |
1970年 | 2846篇 |
1969年 | 2594篇 |
1968年 | 2544篇 |
1967年 | 2378篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Gordon K. B. Saburov V. O. Koryakin S. N. Gulidov I. A. Fatkhudinov T. Kh. Arutyunyan I. V. Kaprin A. D. Solov’ev A. N. 《Bulletin of experimental biology and medicine》2022,173(2):281-285
Bulletin of Experimental Biology and Medicine - Fast neutron therapy, which previously has demonstrated effective results, but along with a large number of complications, can again be considered a... 相似文献
22.
Md Maksudul Alam Janmaris Marin Fermin Patrick T. Spiller Chaning Burnett Xiaohua Rong Tara Moore-Medlin Caden O. Maxwell Alok R. Khandelwal Cherie-Ann O. Nathan 《Molecular carcinogenesis》2022,61(1):33-44
TP53 is the most frequently mutated gene in head and neck squamous cell carcinoma (HNSCC). Patients with HPV-negative TP53 mutant HNSCC have the worst prognosis, necessitating additional agents for treatment. Since mutant p53 causes sustained activation of the PI3K/AKT/mTOR signaling pathway, we investigated the effect of rapalogs RAD001 and CCI-779 on HPV-negative mutTP53 HNSCC cell lines and xenografts. Rapalogs significantly reduced cell viability and colony formation. Interestingly, rapalogs-induced autophagy with no effect on apoptosis. Pretreatment with autophagy inhibitors, 3-methyladenine (3-MA) and ULK-101 rescued the cell viability by inhibiting rapalog-induced autophagy, suggesting that both RAD001 and CCI-779 induce non-apoptotic autophagy-dependent cell death (ADCD). Moreover, rapalogs upregulated the levels of ULK1 and pULK1 S555 with concomitant downregulation of the mTORC1 pathway. However, pretreatment of cells with rapalogs prevented the ULK-101-mediated inhibition of ULK1 to sustained autophagy, suggesting that rapalogs induce ADCD through the activation of ULK1. To further translate our in vitro studies, we investigated the effect of RAD001 in HPV-negative mutTP53 (HN31 and FaDu) tumor cell xenograft model in nude mice. Mice treated with RAD001 exhibited a significant tumor volume reduction without induction of apoptosis, and with a concomitant increase in autophagy. Further, treatment with RAD001 was associated with a considerable increase in pULK1 S555 and ULK1 levels through the inhibition of mTORC1. 3-MA reversed the effect of RAD001 on FaDu tumor growth suggesting that RAD001 promotes ACDC in HPV-negative mutTP53 xenograft. This is the first report demonstrating that rapalogs promote non-apoptotic ADCD in HPV-negative mutTP53 HNSCC via the ULK1 pathway. Further studies are required to establish the promising role of rapalogs in preventing the regrowth of HPV-negative mutTP53 HNSCC. 相似文献
23.
24.
25.
Cheryl L. Rock PhD RD Cynthia A. Thomson PhD RD Kristen R. Sullivan MS MPH Carol L. Howe MD MLS Lawrence H. Kushi ScD Bette J. Caan DrPH Marian L. Neuhouser PhD RD Elisa V. Bandera MD PhD Ying Wang PhD Kimberly Robien PhD RD Karen M. Basen-Engquist PhD MPH Justin C. Brown PhD Kerry S. Courneya PhD Tracy E. Crane PhD RDN David O. Garcia PhD FACSM Barbara L. Grant MS RDN CSO FAND Kathryn K. Hamilton MA RDN CSO CDN FAND Sheri J. Hartman PhD Stacey A. Kenfield ScD Maria Elena Martinez PhD Jeffrey A. Meyerhardt MD MPH Larissa Nekhlyudov MD MPH Linda Overholser MD Alpa V. Patel PhD Bernardine M. Pinto PhD Mary E. Platek PhD RD CDN Erika Rees-Punia PhD MPH Colleen K. Spees PhD MEd RD LD FAND Susan M. Gapstur PhD Marjorie L. McCullough ScD RD 《CA: a cancer journal for clinicians》2022,72(3):230-262
The overall 5-year relative survival rate for all cancers combined is now 68%, and there are over 16.9 million survivors in the United States. Evidence from laboratory and observational studies suggests that factors such as diet, physical activity, and obesity may affect risk for recurrence and overall survival after a cancer diagnosis. The purpose of this American Cancer Society guideline is to provide evidence-based, cancer-specific recommendations for anthropometric parameters, physical activity, diet, and alcohol intake for reducing recurrence and cancer-specific and overall mortality. The audiences for this guideline are health care providers caring for cancer survivors as well as cancer survivors and their families. The guideline is intended to serve as a resource for informing American Cancer Society programs, health policy, and the media. Sources of evidence that form the basis of this guideline are systematic literature reviews, meta-analyses, pooled analyses of cohort studies, and large randomized clinical trials published since 2012. Recommendations for nutrition and physical activity during cancer treatment, informed by current practice, large cancer care organizations, and reviews of other expert bodies, are also presented. To provide additional context for the guidelines, the authors also include information on the relationship between health-related behaviors and comorbidities, long-term sequelae and patient-reported outcomes, and health disparities, with attention to enabling survivors' ability to adhere to recommendations. Approaches to meet survivors' needs are addressed as well as clinical care coordination and resources for nutrition and physical activity counseling after a cancer diagnosis. 相似文献
26.
Chumakov E. M. Petrova N. N. Limankin O. V. Ashenbrenner Yu. V. 《Neuroscience and behavioral physiology》2022,52(1):45-51
Neuroscience and Behavioral Physiology - Objective. To determine the frequency, structure, and severity of cognitive impairments in patients with bipolar affective disorder (BAD) in remission.... 相似文献
27.
28.
F. Dezoteux R. Dubois G. Lefèvre J.P. Lecoutre D. Staumont-Sallé O. Carpentier 《European annals of otorhinolaryngology, head and neck diseases》2019,136(1):47-49
Introduction
Kimura disease (KD) is a chronic lymphoproliferative disorder of unknown etiology that affects the skin and lymph nodes, mostly observed in males of Asian descent. The natural history of asymptomatic epiglottal KD remains unknown. This rare site of KD is often only diagnosed when tumor growth starts to obstruct the upper airways.Observation
A 34-year-old North African male presented with fatigue and multiple, slowly progressive, fluctuating skin nodules in the right mandibular and retroauricular regions. Computed tomography of the head and neck revealed a large soft tissue tumor close to the right mandibular body and unexpected thickening of the epiglottis. Transnasal laryngoscopy confirmed the CT findings and showed thickening of the epiglottis. The diagnosis of KD was based on histological examination of biopsy specimens taken from the right mandibular tumor, a cervical lymph node, and the epiglottis.Discussion
Most cases of KD with epiglottal involvement present with dysphonia and dysphagia. No consensus guidelines are available concerning the complementary investigations that should be performed. This case report raises the question of whether patients with suspected KD should be systematically screened for lesions in unusual and potentially dangerous anatomic sites. 相似文献29.